Anavex Life Sciences Corp (AVXL)

[blu_1]

I feel that the chance or general effect possibilities are far more likely than a true treatment effect.

Anything is possible, but it is unlikely and unexpected that a group of Alzheimers patients selected for both wild-type Sigmar1 AND COMT genes would normally see their average scores for BOTH mmse and adsc-adl improve after 57 weeks.